Abstract: The present invention relates to compounds described herein Formula (I) and pharmaceutical acceptable salts thereof which modulate the activity of calcium release activated calcium (CRAC) channel. The invention also describes the compounds of Formula (I) and pharmaceutical compositions containing such compounds thereof for treating managing and/or lessening the severity of diseases disorders syndromes or conditions associated with the modulation of calcium release activated calcium (CRAC) channel.
| # | Name | Date |
|---|---|---|
| 1 | 2127-MUMNP-2014-AbandonedLetter.pdf | 2024-02-09 |
| 1 | 2127-MUMNP-2014-FORM 1(19-11-2014).pdf | 2014-11-19 |
| 2 | 2127-MUMNP-2014-CORRESPONDENCE(19-11-2014).pdf | 2014-11-19 |
| 2 | 2127-MUMNP-2014-FORM 3 [10-11-2018(online)].pdf | 2018-11-10 |
| 3 | Other Document [24-08-2016(online)].pdf | 2016-08-24 |
| 3 | 2127-MUMNP-2014-ANNEXURE TO FORM 3-(09-02-15).pdf | 2018-08-11 |
| 4 | Form 13 [24-08-2016(online)].pdf | 2016-08-24 |
| 4 | 2127-MUMNP-2014-CORRESPONDENCE-(09-02-15).pdf | 2018-08-11 |
| 5 | Other Patent Document [09-05-2017(online)].pdf | 2017-05-09 |
| 5 | 2127-MUMNP-2014-Correspondence-130115.pdf | 2018-08-11 |
| 6 | 2127-MUMNP-2014-FORM 3 [11-04-2018(online)].pdf | 2018-04-11 |
| 6 | 2127-MUMNP-2014-FER.pdf | 2018-08-11 |
| 7 | PCT IB 304.pdf | 2018-08-11 |
| 7 | 2127-MUMNP-2014-Form 3-130115.pdf | 2018-08-11 |
| 8 | GPA of Lupin Limited.pdf | 2018-08-11 |
| 8 | 2127-MUMNP-2014.pdf | 2018-08-11 |
| 9 | ABSTRACT1.jpg | 2018-08-11 |
| 9 | FORM 5.pdf | 2018-08-11 |
| 10 | FORM 2 & Complete Specification.pdf | 2018-08-11 |
| 10 | FORM 3.pdf | 2018-08-11 |
| 11 | FORM 2 & Complete Specification.pdf | 2018-08-11 |
| 11 | FORM 3.pdf | 2018-08-11 |
| 12 | ABSTRACT1.jpg | 2018-08-11 |
| 12 | FORM 5.pdf | 2018-08-11 |
| 13 | 2127-MUMNP-2014.pdf | 2018-08-11 |
| 13 | GPA of Lupin Limited.pdf | 2018-08-11 |
| 14 | 2127-MUMNP-2014-Form 3-130115.pdf | 2018-08-11 |
| 14 | PCT IB 304.pdf | 2018-08-11 |
| 15 | 2127-MUMNP-2014-FER.pdf | 2018-08-11 |
| 15 | 2127-MUMNP-2014-FORM 3 [11-04-2018(online)].pdf | 2018-04-11 |
| 16 | 2127-MUMNP-2014-Correspondence-130115.pdf | 2018-08-11 |
| 16 | Other Patent Document [09-05-2017(online)].pdf | 2017-05-09 |
| 17 | 2127-MUMNP-2014-CORRESPONDENCE-(09-02-15).pdf | 2018-08-11 |
| 17 | Form 13 [24-08-2016(online)].pdf | 2016-08-24 |
| 18 | Other Document [24-08-2016(online)].pdf | 2016-08-24 |
| 18 | 2127-MUMNP-2014-ANNEXURE TO FORM 3-(09-02-15).pdf | 2018-08-11 |
| 19 | 2127-MUMNP-2014-FORM 3 [10-11-2018(online)].pdf | 2018-11-10 |
| 19 | 2127-MUMNP-2014-CORRESPONDENCE(19-11-2014).pdf | 2014-11-19 |
| 20 | 2127-MUMNP-2014-FORM 1(19-11-2014).pdf | 2014-11-19 |
| 20 | 2127-MUMNP-2014-AbandonedLetter.pdf | 2024-02-09 |
| 1 | SearchStrategy2127_31-05-2018.pdf |